Abstract: Examples described herein include systems and methods for providing dynamic serviceability for a software-defined data center (“SDDC”). An example method can include collecting data-center metrics from a management service that monitors the SDDC, filtering the data-center information based on a predetermined list of metrics provided by a partner entity, and translating the filtered data-center information into a partner-specific format requested by the partner entity. The example method can also include generating metadata associated with the translated data-center information and transmitting the metadata and translated data-center information to a partner site associated with the partner entity. If the partner site is not available, the method can include transmitting the information to a partner-accessible storage location and, when the partner site becomes available, identifying the storage location and failed attempt to deliver the information.

Abstract: A method and system may reduce latency and improve connectivity by performing offline authorization of products and services related to airline reservations. A server device may receive a request for a product or service related to an airline reservation from a user including payment information for the user and may transmit the payment information to a payment service provider for authorization. In response to identifying an outage at the payment service provider, the server device generates a temporary approval code indicative of a successful payment to prevent latency during the outage at the payment service provider and stores transaction data including a representation of the payment information for the user in an offline database. The server device proceeds as if payment was successful and provides an order confirmation message to the user's client device indicating that the product or service has been reserved for the user.

Abstract: The disclosure provides an approach for processing frames of a virtualized desktop to improve accessibility for users, such as users with disabilities. The approach involves processing frames by an accessibility engine that is located on a client device of the user. The virtualized desktop runs on a virtual machine that is remote to the client device. The location of the accessibility engine on the client device allows advantages such as the ability to process frames that indicate a non-operational virtual machine.

Abstract: Embodiments of the present disclosure relate to providing an augmented reality experience. Embodiments include receiving, from an augmented reality or virtual reality (AR/VR) device, first input that identifies application content and a location of an artifact in an AR/VR environment. Embodiments include identifying a region in the environment based on the location, the region corresponding to the artifact. Embodiments include receiving the application content from an application. Embodiments include composing a first scene, the application content being overlaid onto the region. Embodiments include transporting the first scene to the AR/VR device for display. Embodiments include receiving, from the client device, second input in the region in the environment. Embodiments include composing a second scene wherein the application content is modified based on the second input. Embodiments include transporting the second scene to the AR/VR device for display.

Abstract: Embodiments of the present disclosure relate to providing an augmented reality experience. Embodiments include receiving, from an augmented reality or virtual reality (AR/VR) device, first input that identifies application content and a location of an artifact in an AR/VR environment. Embodiments include identifying a region in the environment based on the location, the region corresponding to the artifact. Embodiments include receiving the application content from an application. Embodiments include composing a first scene, the application content being overlaid onto the region. Embodiments include transporting the first scene to the AR/VR device for display. Embodiments include receiving, from the client device, second input in the region in the environment. Embodiments include composing a second scene wherein the application content is modified based on the second input. Embodiments include transporting the second scene to the AR/VR device for display.

Abstract: Methods, systems, and computer-readable media are disclosed herein for generating a user-interactive partogram in a graphical user interface using cloud deployment and multi-application integration.

Abstract: A method and system may reduce latency and improve connectivity by performing offline authorization of products and services related to airline reservations. A server device may receive a request for a product or service related to an airline reservation from a user including payment information for the user and may transmit the payment information to a payment service provider for authorization. In response to identifying an outage at the payment service provider, the server device generates a temporary approval code indicative of a successful payment to prevent latency during the outage at the payment service provider and stores transaction data including a representation of the payment information for the user in an offline database. The server device proceeds as if payment was successful and provides an order confirmation message to the user's client device indicating that the product or service has been reserved for the user.

Abstract: Embodiments of the present disclosure relate to providing an augmented reality experience. Embodiments include receiving, from an augmented reality or virtual reality (AR/VR) device, first input that identifies application content and a location of an artifact in an AR/VR environment. Embodiments include identifying a region in the environment based on the location, the region corresponding to the artifact. Embodiments include receiving the application content from an application. Embodiments include composing a first scene, the application content being overlaid onto the region. Embodiments include transporting the first scene to the AR/VR device for display. Embodiments include receiving, from the client device, second input in the region in the environment. Embodiments include composing a second scene wherein the application content is modified based on the second input. Embodiments include transporting the second scene to the AR/VR device for display.

Abstract: The present application provides novel quinazolines and azaquinazolines and pharmaceutically acceptable salts thereof. Also provided are methods for preparing these compounds. These compounds are useful in for co-regulating RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways by administering a therapeutically effective amount of one or more of the compounds of formula (I), wherein X, Y, T and R4, and R6 to R8? are defined herein, to a patient. By doing so, these compounds are effective in treating conditions associated with the dysregulation of the RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways. A variety of conditions can be treated using these compounds and include diseases which are characterized by abnormal cellular proliferation. In one embodiment, the disease is cancer.

Abstract: Embodiments of the present disclosure relate to providing an augmented reality experience. Embodiments include receiving, from an augmented reality or virtual reality (AR/VR) device, first input that identifies application content and a location of an artifact in an AR/VR environment. Embodiments include identifying a region in the environment based on the location, the region corresponding to the artifact. Embodiments include receiving the application content from an application. Embodiments include composing a first scene, the application content being overlaid onto the region. Embodiments include transporting the first scene to the AR/VR device for display. Embodiments include receiving, from the client device, second input in the region in the environment. Embodiments include composing a second scene wherein the application content is modified based on the second input. Embodiments include transporting the second scene to the AR/VR device for display.

Abstract: The present application provides novel quinazolines and azaquinazolines and pharmaceutically acceptable salts thereof. Also provided are methods for preparing these compounds. These compounds are useful in for co-regulating RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways by administering a therapeutically effective amount of one or more of the compounds of formula (I), wherein X, Y, T and R4, and R6 to R8? are defined herein, to a patient. By doing so, these compounds are effective in treating conditions associated with the dysregulation of the RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways. A variety of conditions can be treated using these compounds and include diseases which are characterized by abnormal cellular proliferation. In one embodiment, the disease is cancer.

Abstract: One embodiment provides a method, including: collecting, at an information handling device, at least one signal received from a living object, in response to an event associated with the living object, wherein the living object is in a communicative state with a person talking to the living object; extracting, using a processor, a set of predetermined features from the signal collected; and determining, responsive to extracting, an intent associated with the living object in response to the event posed to the living object from the strength of the signal. Other embodiments are disclosed and described.

Abstract: The present application provides novel quinazolines and azaquinazolines and pharmaceutically acceptable salts thereof. Also provided are methods for preparing these compounds. These compounds are useful in for co-regulating RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways by administering a therapeutically effective amount of one or more of the compounds of formula (I), wherein X, Y, T and R4, and R6 to R8? are defined herein, to a patient. By doing so, these compounds are effective in treating conditions associated with the dysregulation of the RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways. A variety of conditions can be treated using these compounds and include diseases which are characterized by abnormal cellular proliferation. In one embodiment, the disease is cancer.

Abstract: Embodiments of the present disclosure relate to providing an augmented reality experience. Embodiments include receiving, from an augmented reality or virtual reality (AR/VR) device, first input that identifies application content and a location of an artifact in an AR/VR environment. Embodiments include identifying a region in the environment based on the location, the region corresponding to the artifact. Embodiments include receiving the application content from an application. Embodiments include composing a first scene, the application content being overlaid onto the region. Embodiments include transporting the first scene to the AR/VR device for display. Embodiments include receiving, from the client device, second input in the region in the environment. Embodiments include composing a second scene wherein the application content is modified based on the second input. Embodiments include transporting the second scene to the AR/VR device for display.

Abstract: The disclosure provides an approach for processing frames of a virtualized desktop to improve accessibility for users, such as users with disabilities. The approach involves processing frames by an accessibility engine that is located on a client device of the user. The virtualized desktop runs on a virtual machine that is remote to the client device. The location of the accessibility engine on the client device allows advantages such as the ability to process frames that indicate a non-operational virtual machine.

Abstract: Embodiments of the present disclosure relate to synthesizing a virtual stereo device. Embodiments include receiving a request from a user to synthesize the virtual stereo device based on a first camera and a second camera associated with a client device. Embodiments include calibrating the virtual stereo device by using images received from the first camera and the second camera to determine calibration parameters. Embodiments include storing the calibration parameters in a manifest file and transmitting the manifest file to the client device. Embodiments include receiving encoded frames associated with the virtual stereo device from the client device, each of the encoded frames including a stereo image that has been created by the client device, based on the calibration parameters in the manifest file, from image data captured using the first camera and the second camera. Embodiments include decoding the encoded frames for use by an application involving stereo vision.

Abstract: Examples described herein include systems and methods for providing dynamic serviceability for a software-defined data center (“SDDC”). An example method can include collecting data-center metrics from a management service that monitors the SDDC, filtering the data-center information based on a predetermined list of metrics provided by a partner entity, and translating the filtered data-center information into a partner-specific format requested by the partner entity. The example method can also include generating metadata associated with the translated data-center information and transmitting the metadata and translated data-center information to a partner site associated with the partner entity. If the partner site is not available, the method can include transmitting the information to a partner-accessible storage location and, when the partner site becomes available, identifying the storage location and failed attempt to deliver the information.

Abstract: The present application provides novel quinazolines and azaquinazolines and pharmaceutically acceptable salts thereof. Also provided are methods for preparing these compounds. These compounds are useful in for co-regulating RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways by administering a therapeutically effective amount of one or more of the compounds of formula (I), wherein X, Y, T and R4, and R6 to R8? are defined herein, to a patient. By doing so, these compounds are effective in treating conditions associated with the dysregulation of the RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways. A variety of conditions can be treated using these compounds and include diseases which are characterized by abnormal cellular proliferation. In one embodiment, the disease is cancer.

Abstract: The present application provides novel quinazolines and azaquinazolines and pharmaceutically acceptable salts thereof. Also provided are methods for preparing these compounds. These compounds are useful in for co-regulating RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways by administering a therapeutically effective amount of one or more of the compounds of formula (I), wherein X, Y, T and R4, and R6 to R8? are defined herein, to a patient. By doing so, these compounds are effective in treating conditions associated with the dysregulation of the RAS/RAF/MEK/ERK and PI3K/AKT/PTEN/mTOR pathways. A variety of conditions can be treated using these compounds and include diseases which are characterized by abnormal cellular proliferation. In one embodiment, the disease is cancer.

Abstract: One embodiment provides a method, including: collecting, at an information handling device, at least one signal received from a living object, in response to an event associated with the living object, wherein the living object is in a communicative state with a person talking to the living object; extracting, using a processor, a set of pre-determined features from the signal collected; and determining, responsive to extracting, an intent associated with the living object in response to the event posed to the living object from the strength of the signal.